Back to Results
First PageMeta Content
Biomolecules / Enzyme / Metabolism / Biopharmaceutical / OTC Markets Group / G4 / Chemistry / Television in the United States / Catalysis


Dyadic Announces Launch of Fibrezyme® G4 JUPITER, Fla., April 24, Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of
Add to Reading List

Document Date: 2015-02-27 09:04:47


Open Document

File Size: 46,39 KB

Share Result on Facebook

City

JUPITER / /

Company

Dyadic International Inc. / /

Country

China / /

/

Event

Product Release / /

IndustryTerm

paper-making applications / biotechnology / enzyme products / bio-based chemicals / energy requirements / platform technology / cellulase enzyme product / manufacturing / pharmaceutical / bio-based chemical / biopharmaceutical and industrial enzyme industries / textile manufacturing processes / manufacturing processes / food / manufacturing process / /

Person

Danai Brooks / Rich Jundzil / /

Position

Chief Operating Officer / Vice President of Operations / /

Product

C1 / Fibrezyme G4 / a high performance cellulase enzyme product / C1 platform / Fibrezyme / Fibrezyme G4 / /

ProvinceOrState

Florida / /

Region

South Asia / /

Technology

biotechnology / C1 platform technology / /

URL

www.otcmarkets.com/stock/DYAI/quote / www.dyadic.com / /

SocialTag